Every earnings call for LUPIN — management tone, guidance, KPIs and promise tracking, quarter by quarter.
LUPIN · 6 transcripts · Healthcare · latest Q4 FY26Lupin Limited has 6 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
EBITDA ₹2,171 cr (+68% YoY); EBITDA Margin 29.4% (+6% YoY); ROCE 28.4%. Total revenue from operations grew 32% YoY to INR 7,475 crores in Q4 FY26.
Read full transcript & analysisRevenue ₹7,168 cr (+24% YoY); EBITDA (excl. Forex & Other Income) ₹2,210 cr (+62% YoY); EBITDA Margin (excl. Forex & Other Income) 31.1% (+28% YoY). Total revenue grew 24% YoY to INR 7,168 crores.
Read full transcript & analysisRevenue from Operations ₹7,048 cr (+24% YoY); EBITDA ₹2,138 cr (+63% YoY); EBITDA Margin 31.3% (+8% YoY). Total revenue from operations exceeded INR 7,000 crores for the first time.
Read full transcript & analysisEBITDA ₹1,641 cr (+28% YoY); EBITDA Margin 26.6%. Sales for Q1 FY26 came in at INR 6,164 crores, a growth of 11.8% YoY.
Read full transcript & analysisRevenue 2.7 billion; EBITDA 625 million; EBITDA Margin 23.2%. FY25 revenue reached USD 2.7 billion, with USD 625 million EBITDA.
Read full transcript & analysisRevenue ₹5,619 cr (+11% YoY); EBITDA ₹1,366 cr (+34% YoY); EBITDA Margin 24.3% (+4% YoY). Revenue of ₹5,619 crores, up 10.6% YoY.
Read full transcript & analysis